QURE

$QURE This is my 3rd position on QURE for the last 3 years and I have generated more than 1000% cumulative returns. My current 3rd position has 94.68% profit and I will not take profit. For those of you worried about Ad Com, you obviously didn't do much research on Huntington Disease and enrollment criteria. I will say don't worry and offer my 3 insights. HD deteriorates rapidly at 3rd year and QURE already has secured robust functional data. Biomarker data is secondary to functional data and still robust. I have listened to the entire Ad Com for both CAPR (6H) and REPL (7H) last week. Compared to clinical data shortcomings the FDA validly raised on these two companies, HD data is solid. Some weak hands or novice specialists may point to limited dataset and natural history data instead of placebo. My simple answer is do not worry. Ad Com will work in favor of, rather than against, QURE. HD is rare disease and current LT data is more than sufficient to get FDA approval.

$REPL for anyone following my trades, I sold into close to the peak for a very healthy gain, one of those of its good to screenshot its good to sell. I’m keeping a very small portion of shares just for the heck of it, hedged just for the heck of it x2. CRL is still a possibility, I don’t like to talk in 100% certainties unlike some of the ass bears in this thread. If it gets approved i get some extra dough , nothing crazy. If refused it’s chill, already made plenty. Next moves? I parked some of the profits on my core safe holdings , in this case Apple. Also I doubled my position on $QURE . Other pharma companies? I need to go back to the cave for the deep dives. Im really tempted to buy more sarepta , but I need to refresh my memory on the arrowhead compounds and where those are at. Maybe a IOVA put? I don’t like to buy puts on pharma companies with actual products so I’ll probably skip that one.

$QURE 80-100+ not saying this is ceiling but I got it at the bottom so I’ll take profit here but no less

$QURE $80-100